Triple

T23186624
Position Surface form Disambiguated ID Type / Status
Subject REGN E579608 entity
Predicate hasUnderlyingCompanyCollaboration P6745 FINISHED
Object Sanofi NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Sanofi | Statement: [REGN, hasUnderlyingCompanyCollaboration, Sanofi]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Sanofi
Context triple: [REGN, hasUnderlyingCompanyCollaboration, Sanofi]
  • A. Sanofi chosen
    Sanofi is a major French multinational pharmaceutical company known for developing prescription medicines, vaccines, and consumer healthcare products worldwide.
  • B. Roche
    Roche is a common surname of French origin borne by various notable individuals across fields such as architecture, politics, and the arts.
  • C. Roche
    Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
  • D. Roche
    Roche is a village and civil parish in Cornwall, England, known for its distinctive granite outcrop and historic chapel perched on Roche Rock.
  • E. Novartis
    Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: hasUnderlyingCompanyCollaboration
Context triple: [REGN, hasUnderlyingCompanyCollaboration, Sanofi]
  • A. hasUnderlyingCompanyOperationsIn
    Indicates that a company’s core or foundational business activities take place within a specified geographic location or jurisdiction.
  • B. containsCollaboration
    Indicates that one entity includes or involves a collaborative relationship or joint activity with another entity.
  • C. hasUnderlyingCompanyBusinessModel
    Indicates that one entity possesses or is based on a specific company business model that underlies its structure, operations, or value creation.
  • D. usesCollaboration
    Indicates that one entity employs or relies on collaborative methods, tools, or partnerships with another entity to achieve a shared goal or perform an activity.
  • E. underlyingCompany chosen
    Indicates that one entity serves as the fundamental or base company upon which another entity (such as a product, instrument, or structure) is built, derived, or dependent.
  • F. None of above.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e245ff8000819090d12008805315b7 completed April 17, 2026, 2:38 p.m.
NER Named-entity recognition batch_69f18fd3aaa08190b9cf7afe4ee5a38d completed April 29, 2026, 4:57 a.m.
PD Predicate disambiguation batch_69ef8a041c0081909afb670d17a5aaba completed April 27, 2026, 4:08 p.m.
Created at: April 17, 2026, 4:05 p.m.